Gujarat Inject (Kerala) Ltd Management Discussions.
Since long the Company was not in a position to carry out any commercial activity. However for the year under reference, Company has started its commercial activity in the field of trading and hence generated revenue amounting of Rs. 1,66,250/-. The manufacturing activity in the field of Pharmaceuticals has been stopped totally. This is mainly because of the entire assets including factory situated kerala has been taken over by Financial Institute under SARFACIE Act.
The management of the Company is in negotiation with a loom processor and try to acquire this process house. As a future plan of action the Company will not only do trading activity but will also start process house. Management is hopeful of improvement of the same in the coming years.
INTERNAL CONTROL AND SYSTEMS
The Company has adequate internal control procedures commensurate with its size and nature of business. These internal policies ensure efficient use and protection of assets and resources, compliance with policies, statutes and reliability as well as promptness of financial reports.
FINANCIAL PERFORMANCE WITH RESPECT TO OPERATIONAL PERFORMANCE
Total income from operations was Rs. 1,66,250/- as against last years figure of Nil.
Profit before Interest, Depreciation, Taxes and Impairment Loss on Fixed Assets:
The Company has earned a profit of Rs. 5,894, as against last years figure of Nil.
Financial Charges continues to be Rs. Nil.
Net Profit After Tax:
The Company has earned profit of Rs. 2.30 Crores as against loss of Rs. 32,598 during the previous year.
There are no material developments on the Human Resource Front.
Statements in the Management Discussion and Analysis may be "forward looking statements" and have been issued as required by applicable Securities Laws and Regulations. There are several factors which would be beyond the control of Management and as such, may affect the actual results which could be different from that envisaged.